Abstract The activation of phase-specific cyclindependent kinases is associated with ordered cell cycle transitions. Among the mammalian Cdks, Cdk2 is essential for liver cancer cell proliferation. The related cycling protein CDK2 was analyzed by 2D-gel and MALDI-TOF/TOF MS mass assay in liver cancer cells, which CDK2 was silenced. The results showed four significantly different spots in cell ribonucleoprotein (similar to ribosomal protein S12, chaperonin 10-related protein, beta-actin and zinc finger protein 276) and four in plasmosin (aldolase A protein, hCG, anonymous protein and tubulin, gamma complex associated protein 2). In the plasmosin, aldolase A catalyzes the production of tublin and actin. Together they regulate the cell cycle and arrest the cell in the S phage. In the cell ribonucleoprotein, proteins with homology to ribosomal protein S12 and chaperonin 10 play a similar role in cell cycle regulation.
Introduction
The G1 cyclin-dependent kinases (Cdks), a family of serine/threonine protein kinases, control the onset of the major cell cycle events, such as DNA synthesis and mitosis (Wadler 2001) . Metazoan cells have multiple Cdks and cyclins that are temporally regulated. In normal cell cycles, cyclin-dependent kinase-2 (Cdk2) pairs with E-and A-type cyclins during S and G2 phase, and cyclindependent kinase-1 (Cdk1) pairs with A-and B-type cyclins during G2 and M phase Hinchcliffe and Sluder 2002) . In the cell cycle, the importance of Cdk regulated transitions was first suggested by studies in which the introduction of inhibitory antibodies or the expression of dominant negative mutants or small molecule inhibitors caused phase-specific cell cycle arrest (Golsteyn 2005) . Recent genetic studies, however, have called into question the requirement for multiple Cdks (Golsteyn 2005; Copeland et al. 2010) . In human cells, RNAimediated depletion of Cdks showed that Cdk2 is dispensable for cell cycle progression (Copeland et al. 2010) .
A previous study, the Cdk4/Cdk6-cyclin D pathway has been studied. In this study, we mainly investigated on the Cdk2-cyclin E function in liver cancer cells (Shimura et al. 2012; Bienvenu et al. 2001) . In somatic cells, the G1/S transition is governed by Cdk2-cyclin E complexes through their action on several targets (Chung and Bunz 2010) . Harvey et al. (2000) examined Cdk2 activity in HeLa cells that entered apoptosis after treatment with staurosporine. After expression of Cdk2D145N, a variant that is catalytically inactive, they noted a reduced number of cells that displayed condensed chromatin after treatment with staurosporine (Adon et al. 2010) .
Cyclin-dependent kinases-2 activities are positively regulated by association with different cyclins which are temporally expressed at specific phases of the cell cycle (Hinchcliffe and Sluder 2002) . The detailed mechanism of CKD2 regulation by cyclins in liver cancer cells is still unclear. In this study, CDK2 was inhibited in the liver cancer cells HepG2, the cyclines and cell proliferation were assayed and the subcellular structure proteins were investigated by 2D-image master-MS. This process provides a novel way to study CDK2 and how it affects cell cyclins and cell proliferation.
Materials and methods (M&M)

Cell culture
The liver cancer cell line HepG2 (Chinese Academy of Sciences Cell Bank, Shanghai, China) was grown as a monolayer in RPMI-1640 (Hyclone, Logan, UT, USA) containing 10 % fetal bovine serum (Hyclone). Cells were maintained at 37°C in a humidified incubator under a 5 % CO 2 atmosphere.
RNA interference
Cdk2 small interfering RNAs (siRNAs) was purchased from Santa Cruz Biotechnology, Inc Santa Cruz, CA, USA). The two siRNA duplex sequences targeting the CDK2 mRNA are NM_001122742.1 (sense, 5 0 -GATCCGGTGTACCCAGTACTGCCATT CAAGACGTGGCAGTACTGGGTACACCTTTTT TGTCGACA-3 0 ; antisense, 3 0 -GCCACATGGGTCA TGACGGTAAGTTCTGCACCGTCATGACCCATG TGGAAAAAACAGCTGTTCGA-5 0 ) and all siRNAs were prepared using a transcription-based method with the Silencer siRNA construction kit (Integrated DNA Technologies, San Diego, CA, USA) according to the manufacturer's instructions. Three days after the addition of complete medium, cell lysates were prepared for appropriate assays.
Transfection of siRNA siRNA transfection was performed according to the lipofectamine protocol supplied by Invitrogen (Carlsbad, CA, USA). Briefly, 1 9 10 5 cells were seeded into six-well plates containing an antibiotic-free medium and incubated overnight at 37°C. For each well, 5 lL siRNA was mixed with 125 lL OPTI-MEM I (Invitrogen). The mixture was then combined with a solution of 5 lL lipofectamine (Invitrogen) in 125 lL OPTI-MEM I. After a 20-min incubation period at room temperature, the mixture was applied to the cells in an appropriate volume of OPTI-MEM I so as to achieve a final concentration of 100 nM for each siRNA. After incubation for 6 h at 37°C, RPMI-1640 supplemented with serum was added to the wells and cells were cultured for an additional 24 h at 37°C before analysis.
Western blotting
Cells were harvested 48 h after transfection, washed with 37°C PBS, and lysed with a phenylmethanesulfonyl fluoride lysis buffer (Invitrogen). After centrifugation at 13,200g for 30 min, the supernatant was analyzed for protein content using the bicinchoninic acid reagent (Sigma, St. Louis, MO, USA). Total protein (50 lg) from each sample was electrophoresed on a 10 % SDS-PAGE gel and transferred to a polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA). The membranes were blocked with PBS containing 5 % fatfree milk (BD, San Jose, CA, USA) and 0.1 % Tween-20 (Sigma) for 30 min at room temperature, and were then incubated with primary anti-CDK2 antibody (Millipore) for at least 1 h at room temperature, or overnight at 4°C. The membranes were washed three times with PBS containing 0.1 % Tween 20, incubated with peroxidase conjugated secondary antibodies (Millipore USA), and developed using the ECL reagent (Pierce Biotechnology Inc., Rockford, IL, USA).
Flow cytometry analysis (FCM)
Cell-cycle distribution was evaluated by 5-bromo-2 0 -deoxyuridine (BrdU) incorporation and propidium iodide staining. Cells were pulsed with 10 lM BrdU (Sigma-Aldrich) for 30 min, trypsinized (0.5 % trypsin-ethylenediaminetetraacetic acid (Taneja and and incubated in 1.1 % sodium citrate with 5 ng/lL ribonuclease A (DNA Lego Ribonuclease A; TopBio, Prague, Czech Republic) and 60 lg/lL propidium iodide (Sigma-Aldrich) for 30 min at 37°C in the dark. Cells were analyzed by flow cytometry on the Cytomics FC 500 machine using the CXP software (Beckman Coulter, Fullerton, CA, USA) following standard procedures. Analysis by MultiCycle (Phoenix Flow Systems, San Diego, CA, USA) was applied to assess cell-cycle distribution.
Ribonucleoprotein and plasmosins obtained
Ribonucleoprotein extract of asynchronously proliferating human HepG2 cells was obtained from a kit (Pierce Biotechnology Inc., Rockford, IL, USA). Extract was diluted in replication buffer (20 mM K-HEPES pH 7.8, 100 mM K-acetate, 1 mM DTT, 1 mM EGTA). The plasmosins extracts were prepared as above using a kit (Pierce Biotechnology Inc.).
Two-dimensional gel electrophoresis
Cell total protein was solubilized and denatured in 350 lL of 2-DE sample buffer 7 M urea, 2 M thiourea, 2 % v/v Triton X-100, 65 mM DTT, 0.5 % v/v Pharmalyte 3-10, and 10 % isopropanol (Pierce). Briefly, samples were applied to 18 cmpH3-10 IPG gel strips (Bio-Rad, Richmond, CA, USA), and submitted to isoelectrofocusing (IEF) using an Ettan IPGphor3 Unit (GE Healthcare, Piscataway, NJ, USA) as recommended by the manufacturer. A voltage of 30 V was applied to the strips for 6 h, followed by 500 V for 1 h, 1,000 V for 1 h, and then 8,000 V for 4 h, with a maximum current of 50 lA per strip, as described by Costa et al. (2011) . After focusing, the proteins on the strips were reduced, alkylated and separated by 12 % SDS-PAGE on a Protean II system (Bio-Rad, USA). After silver-staining, the gels were either stored in 1 % acetic acid or dried in 1:5:30 acetic acid/glycerol/methanol (v/v/v).
Image capture and processing Gels were visualized with colloidal Coomassie staining following an improved blue silver method. Briefly, a gel was fixed for 1 h initially in a fixation solution containing 40 % (v/v) methanol and 10 % (v/v) acetic acid, followed by four Milli-Q water washes (15 min each). Then the gel was stained overnight in the working colloidal ''blue silver'' solution with 0.12 % Coomassie Brilliant Blue G-250 (Sigma), 10 % ammonium sulfate (Sigma), 10 % phosphoric acid (Sigma), and 20 % methanol (Sigma). Subsequently, the gels were destained for 2 h via six Milli-Q water washes (20 min each).
Gels were scanned using a Gel-documentation system on a GS-670 Imaging Densitometer (BioRad). Gels were analyzed with the Image Master 2D Elite (Bio-Rad). Spot intensities were normalized with total valid spot volume in order to minimize the nonexpression related variations in spot intensity and hence accurately provide semiquantitative information across different gels. Differences of C 1.5 in expression (ratio %V) between matched spots were considered significant when a spot group passed statistical analysis (t test, p \ 0.05).
Protein identification by mass spectrometry Differentially expressed protein spots were manually excised from 2-DE gels, and washed sequentially with Cytotechnology (2014) 66:567-574 569 water and 50 % acetonitrile (ACN) in 25 mM ammonium bicarbonate, until they were completely destained. After dehydration with 100 % ACN, the dry gel pieces were digested by adding 10.0 ng/lL trypsin (Promega, Madison, WI, USA) in 25 mM ammonium bicarbonate overnight at 37°C. For MALDI-TOF/TOF MS analysis, 2 lL of the digest peptide was mixed with 1 lL of matrix (100 mM a-cyano-4-hydroxy-cinnamic acid in 50 % acetonitrile (ACN) and 0.1 % trifluoroacetic acid Sigma) on a target plate. MALDI-TOF MS and TOF-TOF tandem MS were performed on a 4,800 Proteomics Analyzer (Applied Biosystems, Foster City, CA, USA), and data were acquired in the positive MS reflector mode with a scan range of 900-4,000 Da, and five monoisotopic precursors (S/ N [ 200) were selected for MS/MS analysis. For interpretation of the mass spectra, a combination of peptide mass fingerprints and peptide fragmentation patterns were used for protein identification in an NCBI nonredundant database using the Mascot search engine (www.matrixscience.com). All mass values were considered monoisotopic, and the mass tolerance was set at 75 ppm. One missed cleavage site was allowed for trypsin digestion, cysteine carbamidomethylation was assumed as a fixed modification, and methionine was assumed to be partially oxidized. Results with CI % (Confidence Interval %) values greater than 95 % were considered to be a positive identification. The identified proteins were then matched to specific processes or functions by searching Gene Ontology (http://www. geneontology.org/).
Results
Down regulation of CDK2 protein expression in HepG2 cells after transfection with siRNA
The cells positively stained by the anti-CDK2 antibody accounted for 95-99 % of the total cell population. The control group showed strongly positive cytoplasmic expression of CDK2 (dark brown-yellow), while the CDK2-siRNA group showed weakly positive cytoplasmic expression (light brown-yellow). Western blotting showed that the CDK2 siRNAtransfected cells expressed significantly less CDK2 than the control groups (Fig. 1) .
CDK2 inhibit HepG2 in G1-S phage
Using FCM, cell cycling was observed. In the CDK2-siRNA group, there were more cells in G1 phase. This indicated that CDK2 expression was affected in the G1-S phase (Fig. 2) .
2-DE maps and protein identification by MALDI-TOF/TOF MS between CDK2-siRNA group and control group
Approximately 300 2-DE spots were detected on each gel after Coomassie brilliant blue G-250 staining, with 95 % of the spots matched on paired gels in cell ribonucleoprotein. Four protein spots were found to be significantly different (threefold or higher) in spot intensity, and they were successfully identified by MALDI-TOF/TOF MS (Fig. 3, Table 1 ). Approximately 100 2-DE spots were detected on each gel, with 90 % of the spots matched on paired gels in plasmosin. Four protein spots were found to be significantly different (threefold or higher) in spot intensity, and they were successfully identified by MALDI-TOF/TOF MS (Fig. 4, Table 2 ).
Discussion
CDK2 together with cyclin E can cause the cells to remain in the S phase. Previously, the function of Fig. 1 siRNA-mediated down-regulation of Cdk2. Cells were transfected with cdk2-siRNA vector or control siRNA. Positive cells were selected by G418 as described 'Experimental Procedures'. As compared to control, cells with the cdk2-siRNA vector reduced the cdk2 protein level by 99 % (n = 5). *P \ 0.05 versus control cyclin E was silenced, and it was shown that the proliferation activity of HepG2 changed. In addition, the different proteins, detected by 2-DE maps and identified by MALDI-TOF/TOF MS, were also expressed in the CDK2 silenced HepG2 (Wang and Liu 2008) . In the CDK2-siRNA group, there was a higher number of cells in the G1 phase (Xu et al. 2010) . CDK2 can promote the cell to transition from the G1 phase to the S phase. During this process, many related proteins participate. By 2-D gel electrophoresis, many different protein spots can be distinguished between the CDK2-siRNA group and the control group. However there were only four spots with significantly different expression in the cell ribonucleoprotein (with homologies to ribosomal protein S12, chaperonin 10-related protein, beta-actin and zinc finger protein 276, respectively) and four in the plasmosin extract (with homologies to aldolase A protein, hCG, anonymous protein and tubulin, gamma complex associated protein 2, respectively).
Ribosomal protein S12 is one of the small subunits in the ribosomal protein. It can regulate the accuracy and rate of translation (Mariottini et al. 1999) . In HepG2 cells, when the CDK2 gene was silenced, an increase in a S12-like ribosomal protein was seen (Maisnier-Patin et al. 2007 ). This may have led to a decrease in the speed of cell translation, and this may have resulted in the arrest of the cell cycle in the S phase (Mariottini et al. 1999) . When the Cdk2 gene was silenced, the cells became stressed and the heat shock protein Chaperonin 10 was overexpressed (Sakane et al. 2004 ). This indicated that nuclear protein expression was largely and complexly changed in CDK2 silenced HepG2. Many proteins with homologies to chaperonin 10 were overexpressed and this may have also contributed to the arrest of the cell cycle in the S phase (Brown et al. 2005) . This changes also took placed in plasmosin. In this study, when CDK2 was silenced, the aldolase A protein, hCG, anonymous protein and tubulin, gamma complex associated protein 2 were expressed at significantly higher levels. hCG can block apoptosis in somatic cells (Cole 2007; Cole and Khanlian 2007 Aldolase A catalyzes the cleavage of fructose 1,6-phosphate into dihydroxyacetone phosphate and glyceraldehyde 3-phosphate in the glycolytic pathway (Ueno et al. 2010) . Besides its glycolytic role, aldolase bundles microtubules by tethering the subunit of tubulin and cross-linking actin filaments (Buscaglia et al. 2003) . Tublin is one of the microtubule associated proteins. In association with the microtubules, it regulates the cycling of cells.
In conclusion, the cycling protein CDK2 is related to the ribonucleoproteins of the cell (similar to ribosomal protein S12, chaperonin 10-related protein, beta-actin and zinc finger protein 276) and the plasmosins of the cell (aldolase A protein, hCG, anonymous protein and tubulin, gamma complex associated protein 2). Aldolase A is involved in the tethering of tubulin and crosslinking of actin filaments. Together they regulate the cell cycle and arrest the cell in the S phase. In the cell, the ribonucleoproteins-proteins with homology to ribosomal protein S12 and chaperonin 10-play a similar role in cell cycle regulation.
